This review focuses on the role of SIRT3, SIRT6, and SIRT7 in fibrotic diseases, analyzes their molecular regulatory mechanisms in pulmonary fibrosis, and summarizes the latest research progress for the therapy of IPF using SIRT3, SIRT6, and SIRT7 as targets. Here, SIRT3 is linked to idiopathic pulmonary fibrosis.